150 participants
A Trial to Study if REGN17372 in Combination With Linvoseltamab is Tolerable for Adult Participants With Relapsed/Refractory Multiple Myeloma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-21
- Start Date:
- 2026-03-26
- Completion:
- 2033-09-30
Conditions
- Relapsed Refractory Multiple Myeloma (RRMM)
Interventions
- DRUG
No Results Yet